Pharmacy Voice has welcomed the proposals outlined in the National Institute of Clinical Excellence’s (NICE) consultation on ‘Preventing type-2 diabetes’ which recommends a greater role for pharmacies in assessing people at risk of the disease.
The proposals would mean that all high-risk patients over 25 years would be screened for type 2 diabetes by GPs, with the remainder being able to complete a self-assessment questionnaire in settings such as pharmacies and shopping centres.
Rob Darracott, Chief Executive at Pharmacy Voice said:
“We welcome the guidance which recommends a greater role for pharmacies in assessing people’s risk of type-2 diabetes. There is no reason why all risk assessments need to be carried out by GPs or in GP surgeries, it makes sense to offer people ease of access through community pharmacy. Through the New Medicine Service, pharmacists are making progress in improving medicines use amongst people with type-2 diabetes and a range of other pharmacy support is already on offer. We encourage commissioners and healthcare professionals to engage community pharmacy local networks as a significant partner in any service re-design.”